Trials / Completed
CompletedNCT00240955
Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients
Efficacy and Safety of Two Immunosuppressive Regimens Mycophenolate Sodium (EC-MPS) With Short-term Steroid Use or Free of Steroids Compared With a Regimen of EC-MPS With Standard Steroids in de Novo Kidney Recipients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
The objective of this study is to assess the long-term safety and tolerability of EC-MPS on the patients who completed the core study and wish to continue treatment on EC-MPS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enteric-coated Mycophenolate sodium (EC-MPS) |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2006-05-01
- Completion
- 2006-05-01
- First posted
- 2005-10-18
- Last updated
- 2017-02-23
Source: ClinicalTrials.gov record NCT00240955. Inclusion in this directory is not an endorsement.